Status:

TERMINATED

Cranial Blocks for Postoperative Anesthesia

Lead Sponsor:

University of Pennsylvania

Conditions:

Craniotomy Surgery

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study compares the standard of care to the standard of care plus the administration of bupivacaine or liposomal bupivacaine in patients receiving craniotomies.

Detailed Description

Objective: To assess the effectiveness of analgesia by scalp nerve block with various agents in the first 72 hours following elective craniotomy. The investigators will employ a randomized, single-bl...

Eligibility Criteria

Inclusion

  • ≥18 years of age
  • Need for elective supratentorial craniotomy
  • Preoperative GCS \> 13

Exclusion

  • Preoperative GCS ≤ 13
  • Child (\<18 years of age)
  • Inability to understand or use the visual analog scale (VAS)
  • Proven or suspected allergy to local anesthetics
  • Craniotomy incision extending beyond the field of the block
  • Patients chronically (more than 2 wk) treated with narcotic medications
  • Previous scalp incision
  • Bilateral craniotomies
  • Allergies to local anesthetics
  • GCS verbal score \< 4 after extubation
  • Patients whose surgeries extend past 6 hours (will be placed on standard of care and removed from study)
  • Patients currently on ergot-type oxytoxic drugs, MAOIs, or certain antidepressants
  • Lactating Mothers

Key Trial Info

Start Date :

September 2 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 20 2021

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT04749797

Start Date

September 2 2020

End Date

July 20 2021

Last Update

September 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104